ASTH vs BWIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 25, 2026

ASTH

54.4
AI Score
VS
ASTH Wins

BWIN

34.1
AI Score

Investment Advisor Scores

ASTH

54score
Recommendation
HOLD

BWIN

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ASTH BWIN Winner
Revenue 1.03B 1.94B ASTH
Net Income -36.65M 34.17M ASTH
Net Margin -3.6% 1.8% ASTH
Operating Income -109.61M 62.85M ASTH
ROE -4.1% 4.1% ASTH
ROA -0.6% 1.5% ASTH
Total Assets 6.17B 2.28B BWIN
Cash 184.50M 400.79M ASTH
Current Ratio 1.07 1.23 ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: -9.6% · 3M: -29.0% BWIN 1M: +5.0% · 3M: +11.8%

Current Technical Phase

ASTH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $34.91

BWIN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 57

RSI (14): 56.9 · Price: $31.77

Fundamentals Snapshot

Metric ASTH BWIN
Market Cap — —
Forward P/E 9.6 12.8
Trailing P/E 43.4 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.3%
Gross Margin 0.1% 0.3%
Operating Margin 0.0% 0.0%
EPS 0.82 -1.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.